Oracle’s High-Stakes AI Gamble Raises Alarm Bells

Oracle is placing an enormous bet on artificial intelligence through its partnership with OpenAI, but this aggressive strategy is generating significant financial concerns rather than investor enthusiasm. Market experts are growing increasingly worried about the company’s balance sheet, with some analysts drawing comparisons to conditions last seen during the 2008 financial crisis. The central question facing investors is whether the technology giant’s expansion plans represent a calculated risk or could potentially lead to financial turmoil.

Debt Concerns Intensify

The company’s shares suffered a dramatic sell-off in November, plummeting more than 26 percent over a 30-day period. This market reaction was triggered by a concerning Morgan Stanley report highlighting that risk premiums for credit default swaps (CDS) have surged to their highest level in three years. Financial experts now assess Oracle’s risk profile as approaching territory not seen since the 2008 financial crisis.

These sobering assessments stem from Oracle’s planned massive financing package. According to reports, the company is negotiating loans and bonds totaling $56 billion. Nearly all of this capital is earmarked for infrastructure development to support its partner OpenAI. While competitors like Microsoft and Google can fund similar investments from their substantial cash reserves, Oracle must take on significant debt to finance this expansion.

Should investors sell immediately? Or is it worth buying Oracle?

Cash Flow Projections and Concentration Risk

Morgan Stanley’s forecasts indicate that this aggressive “all-or-nothing” approach could push Oracle’s free cash flow into negative territory for fiscal year 2025, potentially reaching -$9.7 billion. The situation appears even more concerning looking ahead to 2028, with projections suggesting a deficit exceeding $24 billion as capital expenditures for AI infrastructure development continue to escalate.

Other market observers are also sounding cautionary notes. Analysis firm DA Davidson dramatically reduced its price target from $300 to $200 and downgraded the stock to “Neutral.” The primary concern among experts is the substantial concentration risk: Oracle’s impressive order backlog depends almost entirely on a single client—OpenAI. Without OpenAI’s commitments exceeding $300 billion, the software giant’s growth narrative could collapse like a house of cards.

Critical December Deadline

The pressure on Oracle leadership is building as the stock continues to struggle with its downward trend, trading nearly 40 percent below its 52-week high. All attention now turns to December 8th, when the company releases its quarterly results. Management faces the urgent task of providing clarity about its financing strategy and payment schedule with OpenAI. If executives fail to adequately address concerns about the company’s mounting debt burden, the stock’s decline may have further to run.